Bris­tol My­ers in­tro­duces re­al pa­tients in dig­i­tal and so­cial So­tyk­tu pso­ri­a­sis cam­paign

Bris­tol My­ers Squibb de­buted its brand ad­ver­tis­ing for ris­ing star pso­ri­a­sis drug So­tyk­tu at the splashy Gram­my Awards ear­li­er this year. But now the phar­ma com­pa­ny is adding re­al pa­tients to its ef­forts in a dig­i­tal cam­paign where peo­ple talk about the re­al­i­ties of life with mod­er­ate to se­vere plaque pso­ri­a­sis.

BMS timed the launch of the “Clear Un­der­stand­ing” cam­paign to Au­gust, which is Pso­ri­a­sis Aware­ness Month, said Michael Braun, BMS SVP US im­munol­o­gy, in an email. The goal is to help “in­spire peo­ple liv­ing with mod­er­ate to se­vere plaque pso­ri­a­sis to re­flect up­on their own ex­pe­ri­ences, rec­og­nize the fre­quent com­pro­mis­es made be­cause of their dis­ease, and feel em­pow­ered to talk to their doc­tor about treat­ment op­tions avail­able, in­clud­ing So­tyk­tu,” he said.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER